Evidence map›Paper›PMID 29189984›Full record

ArticleMolecular and cellular biochemistry2018

The role of resveratrol on skeletal muscle cell differentiation and myotube hypertrophy during glucose restriction.

Hannah F Dugdale, David C Hughes, Robert Allan, Colleen S Deane, Christopher R Coxon, James P Morton, Claire E Stewart, Adam P Sharples

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. CaOxidative medicine and cellular longevity · 2021
    Article
  10. Article
  11. Synthesis and Biological Evaluation of HalogenatedMolecules (Basel, Switzerland) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The role of SIRT1 in skeletal muscle function and repair of older mice.Journal of cachexia, sarcopenia and muscle · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Hannah F DugdaleStem Cells, Ageing and Molecular Physiology Research (SCAMP) Unit, Exercise Metabolism and Adaptation Research Group (EMARG), Research Institute for Sport and Exercise Sciences (RISES), Liverpool John Moores University, Liverpool, UK.
David C HughesDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Carver College of Medicine, University of Iowa, Iowa City, IA, 52246, USA.
Robert AllanCentre for Applied Sport and Exercise Sciences, University of Central Lancashire, Preston, UK.
Colleen S DeaneDepartment of Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, Exeter, UK.
Christopher R CoxonSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.
James P MortonStem Cells, Ageing and Molecular Physiology Research (SCAMP) Unit, Exercise Metabolism and Adaptation Research Group (EMARG), Research Institute for Sport and Exercise Sciences (RISES), Liverpool John Moores University, Liverpool, UK.
Claire E StewartStem Cells, Ageing and Molecular Physiology Research (SCAMP) Unit, Exercise Metabolism and Adaptation Research Group (EMARG), Research Institute for Sport and Exercise Sciences (RISES), Liverpool John Moores University, Liverpool, UK.
Adam P SharplesInstitute for Science and Technology in Medicine (ISTM), School of Medicine, Keele University, The Guy Hilton Research Centre, Thornburrow Drive, Hartshill, Staffordshire, ST4 7QB, UK. a.p.sharples@googlemail.com.ORCID http://orcid.org/0000-0003-1526-9400
Liverpool John Moores University · GBKeele University · GBUniversity of Exeter · GBUniversity of Iowa · USUniversity of Lancashire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucose restriction (GR) impairs muscle cell differentiation and evokes myotube atrophy. Resveratrol treatment in skeletal muscle cells improves inflammatory-induced reductions in skeletal muscle cell differentiation. We therefore hypothesised that resveratrol treatment would improve muscle cell differentiation and myotube hypertrophy in differentiating C2C12 myoblasts and mature myotubes during GR. Glucose restriction at 0.6 g/L (3.3 mM) blocked differentiation and myotube hypertrophy versus high-glucose (4.5 g/L or 25 mM) differentiation media (DM) conditions universally used for myoblast culture. Resveratrol (10 µM) treatment increased SIRT1 phosphorylation in DM conditions, yet did not improve differentiation when administered to differentiating myoblasts in GR conditions. Resveratrol did evoke increases in hypertrophy of mature myotubes under DM conditions with corresponding elevated Igf-I and Myhc7 gene expression, coding for the 'slow' type I MYHC protein isoform. Inhibition of SIRT1 via EX-527 administration (100 nM) also reduced myotube diameter and area in DM conditions and resulted in lower gene expression of Myhc 1, 2 and 4 coding for 'intermediate' and 'faster' IIx, IIa and IIb protein isoforms, respectively. Resveratrol treatment did not appear to modulate phosphorylation of energy-sensing protein AMPK or protein translation initiator P70S6K. Importantly, in mature myotubes, resveratrol treatment was able to ameliorate reduced myotube growth in GR conditions over an acute 24-h period, but not over 48-72 h. Overall, resveratrol evoked myotube hypertrophy in DM conditions while favouring 'slower' Myhc gene expression and acutely ameliorated impaired myotube growth observed during glucose restriction.

Indexed as

AnimalsCell DifferentiationCell LineGlucoseMiceMuscle Fibers, SkeletalMuscle ProteinsMuscular DiseasesMyoblasts, SkeletalResveratrolStilbenesGlucoseMuscle ProteinsResveratrolStilbenesAMPKAtrophyDietary restrictionHypertrophyMYHCMyoblastsP70S6KSIRT1

Identifiers

PMID29189984
PMCPMC6002440
OpenAlexW2768552630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.